ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.530,23
-0,83%
S&P 500
5.306,04
0,02%
Dow Jones
38.852,86
0,00%
Euro vs US Dollar
1,08435
-0,09%
Bitcoin
67.876,26
-0,61%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Pacific Biosciences of California Inc (PACB)

  7. Pacific Biosciences of California Inc (PACB) News

PACB

Pacific Biosciences of C... (PACB)

Pacific Biosciences of California Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:PACB
DatumZeitQuelleÜberschriftSymbolFirma
22/05/202423h25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PACBPacific Biosciences of California Inc
15/05/202415h45PR Newswire (US)Ambry Genetics and PacBio Announce Collaboration to Sequence Up to 7,000 Human Genomes Aimed at Providing Answers for Families Battling Rare DiseasesNASDAQ:PACBPacific Biosciences of California Inc
09/05/202422h33Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:PACBPacific Biosciences of California Inc
09/05/202422h21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PACBPacific Biosciences of California Inc
09/05/202422h12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PACBPacific Biosciences of California Inc
09/05/202422h05PR Newswire (US)PacBio Announces First Quarter 2024 Financial ResultsNASDAQ:PACBPacific Biosciences of California Inc
16/04/202414h05PR Newswire (US)PacBio Announces Preliminary First Quarter 2024 Revenue and Updates 2024 Revenue GuidanceNASDAQ:PACBPacific Biosciences of California Inc
27/03/202413h00PR Newswire (US)Estonia National Biobank Selects PacBio to Sequence 10,000 Whole GenomesNASDAQ:PACBPacific Biosciences of California Inc
22/03/202421h30PR Newswire (US)PacBio Grants Equity Incentive Award to New EmployeeNASDAQ:PACBPacific Biosciences of California Inc
12/03/202414h05PR Newswire (US)PacBio Announces PureTarget™ Repeat Expansion Panel, Expanding its Portfolio of End-to-End Clinical Research SolutionsNASDAQ:PACBPacific Biosciences of California Inc
06/03/202423h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PACBPacific Biosciences of California Inc
06/03/202423h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PACBPacific Biosciences of California Inc
06/03/202423h26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PACBPacific Biosciences of California Inc
06/03/202423h22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PACBPacific Biosciences of California Inc
05/03/202400h32Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PACBPacific Biosciences of California Inc
05/03/202400h22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PACBPacific Biosciences of California Inc
26/02/202422h55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PACBPacific Biosciences of California Inc
26/02/202422h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PACBPacific Biosciences of California Inc
26/02/202422h25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PACBPacific Biosciences of California Inc
26/02/202422h19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PACBPacific Biosciences of California Inc
26/02/202422h05PR Newswire (US)PacBio to Present at Upcoming Investor ConferencesNASDAQ:PACBPacific Biosciences of California Inc
22/02/202400h25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PACBPacific Biosciences of California Inc
22/02/202400h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PACBPacific Biosciences of California Inc
22/02/202400h17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PACBPacific Biosciences of California Inc
22/02/202400h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PACBPacific Biosciences of California Inc
20/02/202422h17Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PACBPacific Biosciences of California Inc
16/02/202423h54Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PACBPacific Biosciences of California Inc
16/02/202423h52Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PACBPacific Biosciences of California Inc
16/02/202423h06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PACBPacific Biosciences of California Inc
15/02/202422h07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PACBPacific Biosciences of California Inc
 Showing the most relevant articles for your search:NASDAQ:PACB

Kürzlich von Ihnen besucht

NASDAQ
AAYVPXX
Jpmorgan Chase Bank Na P...
LSE
50JL
Hsbc Bk. Nt26
NYSE
FCEB
Forest City
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten